A Study of Single and Repeated Doses of LY3556050 in Healthy Participants

Summary

The main purpose of this study is to conduct blood tests to measure how much LY3556050 is in the bloodstream and to determine if any age, gender, or food effects exist. The study will also evaluate the safety of LY3556050. This is a 2-part study. In Part 1, single increasing doses of LY3556050 will be given orally and participants will be confined for a 5-day period. In Part 2, multiple increasing doses of LY3556050 will be given orally and participants will be confined for a 14-day period.

Timeline

Start

2016-09-14

Primary completion

2017-06-02

Completion

2017-06-02

Drugs

Indications

No indication recorded.